세계의 소토라십정 시장 보고서(2025년)

Sotorasib tablets are a prescription medicine developed for treating certain cases of non-small cell lung cancer in patients whose tumors carry the KRAS G12C gene mutation. The drug binds to the abnormal KRAS protein, preventing it from transmitting signals that drive uncontrolled cancer cell growth and survival. This targeted inhibition can reduce tumor activity, slow disease progression, and improve treatment outcomes in patients with limited options from standard therapies.

The primary dosage forms of sotorasib tablets include 40 mg, 120 mg, 240 mg, and other strengths. The 40 mg tablets provide a lower-strength option for precise dose adjustments to enhance safety and tolerability. Sotorasib is used across patient populations including adolescents, adults, and seniors. Distribution channels include hospital pharmacies, retail pharmacies, online pharmacies, and others. Key applications include non-small cell lung cancer, colorectal cancer, and additional indications, with end-users comprising hospitals, oncology centers, clinics, and other healthcare providers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The sotorasib tablets market research report is one of a series of new reports from The Business Research Company that provides sotorasib tablets market statistics, including sotorasib tablets industry global market size, regional shares, competitors with the sotorasib tablets market share, sotorasib tablets market segments, market trends, and opportunities, and any further data you may need to thrive in the sotorasib tablets industry. This sotorasib tablets market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sotorasib tablets market size has grown rapidly in recent years. It will grow from $1.71 billion in 2024 to $1.92 billion in 2025 at a compound annual growth rate (CAGR) of 12.5%. Growth in the historic period was driven by the increasing prevalence of non-small cell lung cancer, rising awareness of targeted cancer therapies, growing adoption of precision medicine, expansion of oncology treatment centers, and increasing government support for cancer drugs.

The sotorasib tablets market size is expected to see rapid growth in the next few years. It will grow to $3.04 billion in 2029 at a compound annual growth rate (CAGR) of 12.1%. Growth in the forecast period is expected to be supported by rising investment in KRAS inhibitor research, expansion of sotorasib manufacturing capacity, increasing collaborations between biotech and pharmaceutical companies, growing demand for personalized cancer treatment, and wider adoption of oral targeted therapies. Key trends anticipated for the forecast period include advancements in targeted therapy development, improvements in KRAS mutation detection methods, increased R&D investment in oncology drugs, innovation in oral cancer formulations, and progress in sustainable drug manufacturing practices.

The increasing prevalence of cancer is expected to drive the growth of the sotorasib tablets market in the coming years. Cancer consists of a group of diseases characterized by the uncontrolled growth of abnormal cells that invade surrounding tissues and may spread to other parts of the body. This rising prevalence is largely attributed to an aging population, as older individuals are at significantly higher risk for developing various forms of cancer, with the majority of cases occurring in people over the age of 65. Sotorasib tablets function by selectively and irreversibly targeting the KRAS G12C mutation, effectively locking the mutated protein in an inactive state to prevent the uncontrolled cell growth seen in advanced solid tumors, particularly in cases of non-small cell lung cancer. For example, in February 2024, the World Health Organization, an international organization based in Switzerland focused on public health, reported that over 35 million new cancer cases are projected by 2050, representing a 77 percent increase from the estimated 20 million cases in 2022. Therefore, the growing cancer burden is contributing to the expansion of the sotorasib tablets market.

Key companies operating in the sotorasib tablets market are advancing combination therapies to improve outcomes and overcome treatment resistance. Combination therapies involve the use of two or more drugs that work together to attack cancer through multiple mechanisms. This approach enhances treatment efficacy, delays or overcomes resistance, reduces the chances of recurrence, and improves patient quality of life. For instance, in January 2025, Amgen Inc., a biotechnology company based in the United States, received approval from the United States Food and Drug Administration for the use of sotorasib in combination with panitumumab for adult patients with metastatic colorectal cancer carrying the KRAS G12C mutation who had previously undergone standard chemotherapy. This approval followed the results of the Phase 3 CodeBreaK 300 study, which showed that the combination more than doubled progression-free survival compared to the standard-of-care treatment chosen by investigators. Sotorasib is the first oral inhibitor of the KRAS G12C mutation, functioning by selectively binding to the mutant KRAS protein in its inactive form to halt tumor growth and block cancer-related signaling pathways.

In October 2022, BridgeBio Pharma, a biopharmaceutical company based in the United States with a focus on genetic diseases and cancer, entered into a partnership with Amgen to assess the combination of BBP-398 and Lumakras in patients with non-small cell lung cancer harboring the KRAS G12C mutation. The goal of this partnership is to explore a potentially more effective therapeutic approach for these patients, addressing the significant unmet needs associated with this specific mutation. Amgen is a biopharmaceutical company in the United States that develops therapies for serious illnesses, including sotorasib, a treatment for cancers involving KRAS G12C mutations.

Major players in the sotorasib tablets market are Amgen Inc., Ziska Pharmaceuticals Limited, Everest Pharmaceuticals Inc., Lucius Pharmaceutical Co. Ltd.

North America was the largest region in the sotorasib tablets market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sotorasib tablets report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sotorasib tablets market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sotorasib tablets market consists of sales of lumakras, lumykras, and diagnostic companion kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sotorasib Tablets Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sotorasib tablets market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sotorasib tablets ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sotorasib tablets market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Dosage Form: 40 Milligrams (Mg) Tablets; 120 Milligrams (Mg) Tablets; 240 Milligrams (Mg) Tablets; Other Dosage Forms
• 2) By Patient Demographics: Adolescents; Adult; Senior Adults
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
• 4) By Application: Non-Small Cell Lung Cancer; Colorectal Cancer; Other Applications
• 5) By End-User: Hospitals; Oncology Centers; Clinics; Other End-Users
• Companies Mentioned: Amgen Inc.; Ziska Pharmaceuticals Limited; Everest Pharmaceuticals Inc.; Lucius Pharmaceutical Co. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Sotorasib Tablets Market Characteristics

3. Sotorasib Tablets Market Trends And Strategies

4. Sotorasib Tablets Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Sotorasib Tablets Growth Analysis And Strategic Analysis Framework

• 5.1. Global Sotorasib Tablets PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Sotorasib Tablets Market Growth Rate Analysis
• 5.4. Global Sotorasib Tablets Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Sotorasib Tablets Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Sotorasib Tablets Total Addressable Market (TAM)

6. Sotorasib Tablets Market Segmentation

• 6.1. Global Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 40 Milligrams (Mg) Tablets
• 120 Milligrams (Mg) Tablets
• 240 Milligrams (Mg) Tablets
• Other Dosage Forms
• 6.2. Global Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Adolescents
• Adult
• Senior Adults
• 6.3. Global Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Other Distribution Channels
• 6.4. Global Sotorasib Tablets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-Small Cell Lung Cancer
• Colorectal Cancer
• Other Applications
• 6.5. Global Sotorasib Tablets Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Oncology Centers
• Clinics
• Other End-Users

7. Sotorasib Tablets Market Regional And Country Analysis

• 7.1. Global Sotorasib Tablets Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Sotorasib Tablets Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sotorasib Tablets Market

• 8.1. Asia-Pacific Sotorasib Tablets Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sotorasib Tablets Market

• 9.1. China Sotorasib Tablets Market Overview
• 9.2. China Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sotorasib Tablets Market

• 10.1. India Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sotorasib Tablets Market

• 11.1. Japan Sotorasib Tablets Market Overview
• 11.2. Japan Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sotorasib Tablets Market

• 12.1. Australia Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sotorasib Tablets Market

• 13.1. Indonesia Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sotorasib Tablets Market

• 14.1. South Korea Sotorasib Tablets Market Overview
• 14.2. South Korea Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sotorasib Tablets Market

• 15.1. Western Europe Sotorasib Tablets Market Overview
• 15.2. Western Europe Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sotorasib Tablets Market

• 16.1. UK Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sotorasib Tablets Market

• 17.1. Germany Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sotorasib Tablets Market

• 18.1. France Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sotorasib Tablets Market

• 19.1. Italy Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sotorasib Tablets Market

• 20.1. Spain Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sotorasib Tablets Market

• 21.1. Eastern Europe Sotorasib Tablets Market Overview
• 21.2. Eastern Europe Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sotorasib Tablets Market

• 22.1. Russia Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sotorasib Tablets Market

• 23.1. North America Sotorasib Tablets Market Overview
• 23.2. North America Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sotorasib Tablets Market

• 24.1. USA Sotorasib Tablets Market Overview
• 24.2. USA Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sotorasib Tablets Market

• 25.1. Canada Sotorasib Tablets Market Overview
• 25.2. Canada Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sotorasib Tablets Market

• 26.1. South America Sotorasib Tablets Market Overview
• 26.2. South America Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sotorasib Tablets Market

• 27.1. Brazil Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sotorasib Tablets Market

• 28.1. Middle East Sotorasib Tablets Market Overview
• 28.2. Middle East Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sotorasib Tablets Market

• 29.1. Africa Sotorasib Tablets Market Overview
• 29.2. Africa Sotorasib Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Sotorasib Tablets Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Sotorasib Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sotorasib Tablets Market Competitive Landscape And Company Profiles

• 30.1. Sotorasib Tablets Market Competitive Landscape
• 30.2. Sotorasib Tablets Market Company Profiles
  • 30.2.1. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Ziska Pharmaceuticals Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Everest Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Lucius Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Global Sotorasib Tablets Market Competitive Benchmarking And Dashboard

32. Key Mergers And Acquisitions In The Sotorasib Tablets Market

33. Recent Developments In The Sotorasib Tablets Market

34. Sotorasib Tablets Market High Potential Countries, Segments and Strategies

• 34.1 Sotorasib Tablets Market In 2029 - Countries Offering Most New Opportunities
• 34.2 Sotorasib Tablets Market In 2029 - Segments Offering Most New Opportunities
• 34.3 Sotorasib Tablets Market In 2029 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer